NCT01444872View on ClinicalTrials.gov

Study to Evaluate TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Renal Dysfunction

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

June 30, 2012

Conditions
Heart FailureKidney Disease
Interventions
DRUG

TRV120027

IV infusion

DRUG

Normal Saline

IV infusion

Trial Locations (4)

27705

Duke Clinical Research Unit, Durham

32809

Orlando Clinical Research Center, Orlando

37920

New Orleans Center for Clinical Research, Knoxville

55404

DaVita Clinical Research, Minneapolis

All Listed Sponsors
lead

Trevena Inc.

INDUSTRY

NCT01444872 - Study to Evaluate TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Renal Dysfunction | Biotech Hunter | Biotech Hunter